Friday, November 13, 2026
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
No Result
View All Result

Facebook shares rise following Zuckerberg’s testimony before congressional committees

Freedom Reporter by Freedom Reporter
April 11, 2018
in Breaking News, News
0
zuckerberg
Share on FacebookShare on TwitterShare on Whatsapp

Facebook shares rose sharply, registering its biggest-gain in nearly two years as Chief Executive Mark Zuckerberg answered questions from United States (U.S.) senators on how Facebook might be regulated more-closely.
According to media report on Wednesday, Zuckerberg apologised for the issues that Facebook caused, from data privacy to foreign attempts to influence U.S. elections.
But he avoided any specific talk about new laws.
“I’ll have my team follow up with you so that way we can have this discussion across the different categories where I think this discussion needs to happen,” said Zuckerberg.
He said this in a hearing of  the U.S. Senate’s Commerce and Judiciary committees about the regulations he thought were necessary.
“Zuckerberg is conciliatory in his presentation. The stock is running up on his comments,” said Mariann Montagne, portfolio manager at Gradient Investments in Arden Hills, Minnesota.
Facebook shares closed up 4.5 per cent at 165.04 dollars, its  highest level in almost three weeks. It was its biggest daily gain since April 28, 2016.
 
The shares fell-steeply last month after it was revealed that millions of users’ personal-information was obtained from Facebook by Cambridge Analytica, a political-consultancy that used the information in Donald Trump’s presidential campaign in 2016.
The latest estimate of affected users is up to 87 million.

Tags: zuckerberg
Share25Tweet16Send
Previous Post

Buhari extends VAIDS deadline to June 30

Next Post

‘My wife slept with two members of my church’, pastor tells court; wife replies ‘my husband dating Deacon’s wife’

Next Post
Court dissolves 15-year-old marriage over wife’s nagging

'My wife slept with two members of my church', pastor tells court; wife replies 'my husband dating Deacon's wife'

fec

Osinbajo presides over FEC as Information Ministry presents scorecard

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

https://freedomonline.com.ng/wp-content/uploads/2026/04/VID-20260408-WA0025.mp4
https://freedomonline.com.ng/wp-content/uploads/2025/01/5aeac180-db4e-4e7c-bd37-07ddbf15b053.mp4

Popular Stories

Plugin Install : Popular Post Widget need JNews - View Counter to be installed

Latest Stories

Keyamo

Keyamo accuses Atiku, Obi, opposition leaders of blackmailing judiciary

November 13, 2026

FCCPC seals Peachville Estate offices over non-delivery of N140m property

November 13, 2026

Nigeria Fish Production Rises to 1.4 Million Tonnes – Oyetola

November 13, 2026

FCC Files Criminal Charges Against Customs CG Bashir Adeniyi

November 13, 2026
Tinubu

2027: Violence should never have a place in our political campaigns – Tinubu  

November 13, 2026

CBN Africa Targets ₦10 Million to Support Vulnerable Nigerians Through Telethon.

November 13, 2026

TRCN Uncovers 250 Fake Teaching Certificates, Introduces QR-Code Verification

November 13, 2026
Freedom Online

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.

Navigate Site

  • Home
  • News
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates

Follow Us

No Result
View All Result

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.